Product correctly added to cart.

discount label
Ataluren
View 3D

Biosynth logo

Ataluren

CAS: 775304-57-9

Ref. 3D-FF106142

1g
159.00 €
2g
229.00 €
5g
403.00 €
10g
598.00 €
500mg
98.00 €
Estimated delivery in United States, on Tuesday 28 May 2024

Product Information

Name:
Ataluren
Synonyms:
  • 3-[5-(2-Fluorophenyl)-1,2,4-oxadiazol-3-yl]benzoic acidPTC 124
  • 3-[5-(2-Fluorophenyl)-1,2,4-oxadiazol-3-yl]benzoicacid
  • Atalure
  • Benzoic acid,3-[5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl]-
  • Pct 124
  • Ptc 124
  • Translarna
Description:

Ataluren is a drug that was developed to treat Duchenne muscular dystrophy. It is an orally administered small molecule that has been shown to restore the production of a protein called dystrophin, which is missing in people with Duchenne muscular dystrophy. The drug works by binding to the RNA polymerase and terminating transcription of the mutated gene that causes the disease. Ataluren has been studied in clinical trials as an alternative to steroids, which are used to slow or stop muscle deterioration and allow the body's natural healing process to take place. This drug has also been shown to be effective against other mutations, including those associated with cystic fibrosis and Huntington's disease.

Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
284.24 g/mol
Formula:
C15H9FN2O3
Purity:
Min. 95%
Color/Form:
Powder
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-FF106142 Ataluren

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".